semaglutide side effects vision Effects: What Patients Should Know in 2025 Vision loss with GLP-1s: Wegovy

A brand-new, March 2026 systematic review of semaglutide pancreatitis riskwhich is still in pre-print, and may not hold up to peer reviewconcluded semaglutide was not associated with an increased risk of acute pancreatitis compared to placebo

Some studies have suggested that taking Ozempic may increase someones risk of developing NAION

GLP-1 receptor agonists slow gastric emptying, meaning food remains in the stomach longer than usual

The ICD-10 code for morbid obesity is E66.01 and being knowledgeable about this code and its application to your patients can greatly improve the accuracy of diagnosis and ensure appropriate reimbursement from insurance providers and other payers